Frank D. Heuszel, Chief Executive Officer at IMPACT BIOMEDICAL INC. (IBO), bought 1,050 shares at $2.59 ($3K) on 2024-11-26, disclosed to the SEC on 2024-12-03.
Open-market purchase of $3k IBO by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.59 | 500 | $1K | 47.2% |
| 2 | $2.63 | 550 | $1K | 52.8% |
| Total | $2.61 avg | 1,050 | $3K | 100% |
| Filing → |